Pirfenidone Tablets IP 200 mg is a pharmaceutical-grade tablet designed specifically for the treatment and management of respiratory conditions such as idiopathic pulmonary fibrosis. This meticulously formulated medication offers a precise 200 mg dosage of active Pirfenidone, ensuring therapeutic efficacy while maintaining consistent quality aligned with international healthcare standards. Manufactured under stringent WHO-GMP compliant processes at IndiGlobal Exports, these tablets are produced with export-grade quality materials and packaging to meet global regulatory demands. The formulation is available in blister or strip packs designed for safe bulk export and institutional distribution. Ideal for hospitals, clinics, and retail pharmacies, these tablets provide reliable therapeutic performance and enhance patient adherence through their convenient and accurately measured dosage form. Each batch undergoes rigorous quality control and complies with Pharmacopoeial standards (IP/USP), making Pirfenidone Tablets IP 200 mg a trustworthy choice for managing respiratory ailments in both regulated and semi-regulated markets.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Pirfenidone 200 mg per tablet |
| Indication | Management of respiratory conditions including idiopathic pulmonary fibrosis |
| Dosage Form | Oral Tablet |
| Manufacturing Standards | WHO-GMP compliant manufacturing facility |
| Packaging | Export-grade blister or strip packs |
| Quality Compliance | Meets IP and USP pharmacopoeial standards |
| Shelf Life | As per regulatory guidelines |
| Manufacturer | IndiGlobal Exports |
| Market Suitability | Ideal for regulated and semi-regulated international pharmaceutical markets |
| Therapeutic Effect | Reliable performance ensuring consistent dosage and efficacy |
| Attributes | Description |
|---|---|
| Category | Respiratory Medication |
| Formulation Type | Tablet |
| Strength | 200 mg |
| Packaging Details | Blister/Strip pack suitable for export |
| Shelf Life | Compliant with international regulatory standards |
| Compliance Standards | IP (Indian Pharmacopoeia), USP (United States Pharmacopeia) |
| Manufacturing Location | IndiGlobal Exports, WHO-GMP certified facility |
| Intended Use | Respiratory disease management |
| Export Compliance | Meets global drug regulatory requirements |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
The tablets are manufactured in WHO-GMP certified facilities and comply with both Indian Pharmacopoeia (IP) and United States Pharmacopeia (USP) standards, meeting international healthcare regulations.
Pirfenidone Tablets IP 200 mg are packaged in export-grade blister or strip packs that ensure product stability and protection during bulk shipment to international pharmaceutical markets.
These tablets are primarily used in the management of idiopathic pulmonary fibrosis and other chronic respiratory diseases requiring anti-fibrotic intervention.
IndiGlobal Exports uses stringent manufacturing and quality control processes to maintain precise 200 mg Pirfenidone dosage per tablet, ensuring therapeutic consistency batch-to-batch.
Yes, the tablets meet quality and compliance benchmarks that make them ideal for distribution in both regulated and semi-regulated international pharmaceutical markets.
Brand: indiglobal exports
Country Of Origin: India
Pirfenidone Tablets IP 200 mg is a pharmaceutical product indicated for respiratory treatment. This formulation is manufactured with export-quality standards to ensure therapeutic efficacy, consistent dosage, and compliance with international healthcare regulations.
Features:Pirfenidone Tablets IP 200 mg is developed for the effective management of respiratory conditions, offering reliable performance backed by stringent pharmaceutical standards. Each batch is carefully produced and tested to ensure consistency, safety, and compliance with global export norms.
This formulation supports the clinical treatment and ongoing care of patients with respiratory indications. Commonly prescribed in hospital and retail pharmacy settings, it ensures measurable therapeutic benefit.
Crafted in state-of-the-art facilities, this tablet formulation ensures accuracy in dosing and ease of administration. It is typically available in secure blister or strip packs suitable for bulk export or institutional supply.
The product is manufactured in facilities adhering to WHO-GMP standards and complies with pharmacopoeial quality benchmarks (IP/USP). Ideal for regulated and semi-regulated markets seeking quality-assured medications.
Inclusive of all taxes
You Save: 0
Panchkula , India
Service Provider , Professional Services, Exporter, Wholesaler
GST- 06eogps3248l1zf
